How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product
The Challenge Inbeeo’s client, a large biotech, had received negative recommendations for reimbursement of its novel biologic treatment for severe forms of post-menopausal osteoporosis (PMO).
